Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2010

Nov 15, 2010

30071_dirs_2010-11-15_ddd4051b-f767-443e-abd4-8c8a0ce8efd0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-11-11

Reporting Person: QUINN MICHAEL A (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-11-11 ResMed Common Stock Options $33.70 A 24390 Acquired 2017-11-11 ResMed Common Stock (24390) Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 342000 Direct
ResMed Common Stock 6600 Indirect

Footnotes

F1: Options vest in full (i) on the first Nov. 11 following grant date or (ii) the first annual shareholder's meeting following grant date. Options have a required holding period until the earlier of (i) Nov. 11 of the third year following grant date or (ii) six months following termination of directorship.